Suppr超能文献

急性冠状动脉综合征患者经皮冠状动脉介入治疗后心力衰竭发生的影响因素:一项荟萃分析

Factors influencing the development of heart failure after PCI in patients with acute coronary syndrome: a meta-analysis.

作者信息

Jiang Qian-Zhu, Xu Qian, Wan Dong-Mei, Kong Ying

机构信息

Heilongjiang University of Chinese Medicine Harbin 150001, Heilongjiang, China.

First Ward of Cardiovascular Department, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine Harbin 150001, Heilongjiang, China.

出版信息

Am J Transl Res. 2025 Apr 15;17(4):2352-2375. doi: 10.62347/FPXH3010. eCollection 2025.

Abstract

OBJECTIVE

To systematically analyze the factors associated with heart failure (HF) development after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS).

METHODS

Relevant literature on risk factors for HF following PCI in ACS patients were retrieved from PubMed, Embase, The Cochrane Library, Web of Science, and Medline buildup to September 2024. Two independent investigators conducted literature screening, quality assessment, and data extraction based on inclusion and exclusion criteria. Meta-analysis was performed using Stata 12.0 software.

RESULTS

A total of 20 papers were included, comprising 45,578 patients of whom 4,345 ACS patients developed HF after PCI. Meta-analysis identified several predictors of post-PCI HF in ACS patients, including advanced age [odds ratio (OR) =1.04, 95% confidence intervals (CI): 1.03-1.06], female gender (OR=1.43, 95% CI: 1.18-1.72), history of hypertension (OR=1.54, 95% CI: 1.31-1.80), history of diabetes mellitus (OR=1.55, 95% CI: 1.39-1.72), previous myocardial infarction (OR=1.58, 95% CI: 1.11-2.23), anterior wall myocardial infarction (OR=2.22, 95% CI: 1.89-2.61), reduced left ventricular ejection fraction (LVEF) (OR=1.40, 95% CI: 1.21-1.62), elevated white blood cell count (OR=1.14, 95% CI: 1.07-1.22), atrial fibrillation [hazard ratio (HR) =2.14, 95% CI: 1.11-4.12], increased heart rate (OR=1.03, 95% CI: 1.02-1.04), elevated Pentraxin-3 (PTX3) levels (OR=2.67, 95% CI: 1.45-4.93), and decreased myocardial contractility (HR=1.18, 95% CI: 1.10-1.26). Notably, complete revascularization (HR=0.29, 95% CI: 0.10-0.86) was identified as a protective factor. Sensitivity analysis confirmed the robustness of these findings.

CONCLUSIONS

Advanced age, female gender, history of hypertension and diabetes, previous myocardial infarction, anterior wall myocardial infarction, decreased LVEF at admission, increased white blood cell count, atrial fibrillation at admission, increased heart rate, elevated PTX3 levels, and impaired myocardial contractility were risk factors for HF development after PCI in ACS patients. Conversely, complete revascularization was associated with a lower risk of post-PCI HF.

摘要

目的

系统分析急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)后发生心力衰竭(HF)的相关因素。

方法

检索截至2024年9月PubMed、Embase、Cochrane图书馆、Web of Science和Medline数据库中关于ACS患者PCI后发生HF危险因素的相关文献。两名独立研究人员根据纳入和排除标准进行文献筛选、质量评估和数据提取。使用Stata 12.0软件进行荟萃分析。

结果

共纳入20篇论文,涉及45578例患者,其中4345例ACS患者在PCI后发生HF。荟萃分析确定了ACS患者PCI后发生HF的几个预测因素,包括高龄[比值比(OR)=1.04,95%置信区间(CI):1.03 - 1.06]、女性(OR = 1.43,95% CI:1.18 - 1.72)、高血压病史(OR = 1.54,95% CI:1.31 - 1.80)、糖尿病病史(OR = 1.55,95% CI:1.39 - 1.72)、既往心肌梗死(OR = 1.58,95% CI:1.11 - 2.23)、前壁心肌梗死(OR = 2.22,95% CI:1.89 - 2.61)、左心室射血分数(LVEF)降低(OR = 1.40,95% CI:1.21 - 1.62)、白细胞计数升高(OR = 1.14,95% CI:1.07 - 1.22)、心房颤动[风险比(HR) = 2.14,95% CI:1.11 - 4.12]、心率加快(OR = 1.03,95% CI:1.02 - 1.04)、五聚体3(PTX3)水平升高(OR = 2.67,95% CI:1.45 - 4.93)以及心肌收缩力下降(HR = 1.18,95% CI:1.10 - 1.26)。值得注意的是,完全血运重建(HR = 0.29,95% CI:0.10 - 0.86)被确定为保护因素。敏感性分析证实了这些结果的稳健性。

结论

高龄、女性、高血压和糖尿病病史、既往心肌梗死、前壁心肌梗死、入院时LVEF降低、白细胞计数升高、入院时心房颤动、心率加快、PTX3水平升高以及心肌收缩力受损是ACS患者PCI后发生HF的危险因素。相反,完全血运重建与PCI后发生HF的风险较低相关。

相似文献

1
Factors influencing the development of heart failure after PCI in patients with acute coronary syndrome: a meta-analysis.
Am J Transl Res. 2025 Apr 15;17(4):2352-2375. doi: 10.62347/FPXH3010. eCollection 2025.
2
Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
ESC Heart Fail. 2024 Apr;11(2):937-949. doi: 10.1002/ehf2.14646. Epub 2024 Jan 15.
3
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
Int J Cardiol. 2023 Jan 1;370:35-42. doi: 10.1016/j.ijcard.2022.10.146. Epub 2022 Oct 25.
8
[Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention].
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Oct 24;47(10):798-805. doi: 10.3760/cma.j.issn.0253-3758.2019.10.006.
9
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
Int J Cardiol. 2024 Feb 15;397:131622. doi: 10.1016/j.ijcard.2023.131622. Epub 2023 Dec 6.

本文引用的文献

2
Association between cardiac time intervals and incident heart failure after acute coronary syndrome.
Int J Cardiovasc Imaging. 2024 Oct;40(10):2145-2155. doi: 10.1007/s10554-024-03206-8. Epub 2024 Aug 3.
3
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
J Am Coll Cardiol. 2024 Jun 11;83(23):2233-2246. doi: 10.1016/j.jacc.2024.03.405. Epub 2024 Apr 6.
5
What underlies sex differences in heart failure onset within the first year after a first myocardial infarction?
Front Cardiovasc Med. 2024 Jan 23;10:1290375. doi: 10.3389/fcvm.2023.1290375. eCollection 2023.
7
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
Int J Cardiol. 2024 Feb 15;397:131622. doi: 10.1016/j.ijcard.2023.131622. Epub 2023 Dec 6.
8
Mechanism of heart failure after myocardial infarction.
J Int Med Res. 2023 Oct;51(10):3000605231202573. doi: 10.1177/03000605231202573.
10
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF.
JACC Heart Fail. 2023 Aug;11(8 Pt 1):879-889. doi: 10.1016/j.jchf.2023.05.026.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验